Modeling the risks and benefits of depression treatment for children and young adults

Value in Health

Volumn 15, Issue 5, 2012, Pages 724-729

  Soeteman, Djora I ^a   Miller, Matthew ^a   Kim, Jane J ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

adolescents; depression; disease simulation model; suicide; treatment

Indexed keywords

FLUOXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR;

ADOLESCENT; ADULT; ARTICLE; CHILD; COGNITIVE THERAPY; DISEASE MODEL; DRUG EFFICACY; EPIDEMIOLOGICAL DATA; FATALITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PEDIATRICS; PRIORITY JOURNAL; REMISSION; RISK BENEFIT ANALYSIS; SCHOOL CHILD; SUICIDAL BEHAVIOR; SUICIDE ATTEMPT; TREATMENT RESPONSE;

ADOLESCENT; CHILD; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; COMPUTER SIMULATION; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; MODELS, THEORETICAL; SEROTONIN UPTAKE INHIBITORS; SUICIDE; SUICIDE, ATTEMPTED; UNITED STATES; YOUNG ADULT;

EID: 84864574467     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1016/j.jval.2012.03.1390     Document Type: Article

References (23)

1. T.A. Hammad, T. Laughren, J. Racoosin Suicidality in pediatric patients treated with antidepressant drugs Arch Gen Psychiatry 63 2006 332 339
2. R.A. Friedman, A.C. Leon Expanding the black box-depression, antidepressants, and the risk of suicide N Engl J Med 356 2007 2343 2346
3. J.A. Bridge, S. Iyengar, C.B. Salary Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials JAMA 297 2007 1683 1696
4. A. Le Lay, N. Despiegel, C. Franois, G. Duru Can discrete event simulation be of use in modelling major depression? Cost Eff Resour Alloc 4 2006 19
5. P. Barton, P. Jobanputra, J. Wilson The use of modelling to evaluate new drugs for patients with a chronic condition: the case of antibodies against tumour necrosis factor in rheumatoid arthritis Health Technol Assess 8 2004 1 104
6. A.J. Rush, H.C. Kraemer, H.A. Sackeim Report by the ACNP task force on response and remission in major depressive disorder Neuropsychopharmacology 31 2006 1841 1853
7. S. Zisook, I. Lesser, J.W. Stewart Effect of age at onset on the course of major depressive disorder Am J Psychiatry 164 2007 1539 1546
8. T.J. Wade, J. Cairney, D.J. Pevalin Emergence of gender differences in depression during adolescence: national panel results from three countries J Am Acad Child Adolesc Psychiatry 41 2002 190 198
9. S.B. Patten A major depression prognosis calculator based on episode duration Clin Pract Epidemol Ment Health 2 2006 13
10. B. Kennard, S. Silva, S. Tonev Remission and recovery in the Treatment for Adolescents with Depression Study (TADS): acute and long-term outcomes J Am Acad Child Adolesc Psychiatry 48 2009 186 195
11. Centers for Disease Control and Prevention Fatal and nonfatal injury data http://www.cdc.gov/injury/wisqars/nonfatal.html http://www.cdc.gov/injury/ wisqars/fatal.html [Accessed April 16, 2012]
12. B. Dubicka, S. Hadley, C. Roberts Suicidal behaviour in youths with depression treated with new-generation antidepressants Br J Psychiatry 189 2006 393 398
13. The TADS Team The Treatment for Adolescents with Depression Study (TADS): long-term effectiveness and safety outcomes Arch Gen Psychiatry 64 2007 1132 1144
14. Centers for Disease Control and Prevention 2004 US life tables http://www.cdc.gov/nchs/products/life-tables.htm [Accessed April 16, 2012]
15. D.A. Solomon, M.B. Keller, A.C. Leon Multiple recurrences of major depressive disorder Am J Psychiatry 157 2000 229 233
16. G.J. Emslie, B.D. Kennard, T.L. Mayes Fluoxetine versus placebo in preventing relapse of major depression in children and adolescents Am J Psychiatry 165 2008 459 467
17. K.M. Holma, T.K. Melartin, J. Haukka Incidence and predictors of suicide attempts in DSM-IV major depressive disorder: a five-year prospective study Am J Psychiatry 167 2010 801 808
18. US Preventive Services Task Force Screening and treatment for major depressive disorder in children and adolescents: US Preventive Services Task Force recommendation statement Pediatrics 123 2009 1223 1228
19. B. Kennard, S. Silva, B. Vitiello Remission and residual symptoms after short-term treatment in the Treatment of Adolescents with Depression Study (TADS) J Am Acad Child Adolesc Psychiatry 45 2006 1404 1411
20. G.I. Spielmans, M.I. Berman, A.N. Usitalo Psychotherapy versus second-generation antidepressants in the treatment of depression J Nerv Ment Dis 199 2011 142 149
21. S. Schneeweiss, A.R. Patrick, D.H. Solomon Comparative safety of antidepressant agents for children and adolescents regarding suicidal acts Pediatrics 125 2010 876 888
22. A.M. Leventhal, D.O. Antonuccio On chemical imbalances, antidepressants, and the diagnosis of depression Ethical Hum Psychol Psychiatry 11 2009 199 214
23. H.E. Pigott, A.M. Leventhal, G.S. Alter, J.J. Boren Efficacy and effectiveness of antidepressants: current status of research Psychother Psychosom 79 2010 267 279